Lipid metabolome-wide effects of the PPARγ agonist rosiglitazones⃞
Successful therapy for chronic diseases must normalize a targeted aspect of metabolism without disrupting the regulation of other metabolic pathways essential for maintaining health. Use of a limited number of single molecule surrogates for disease, or biomarkers, to monitor the efficacy of a therap...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2002-11-01
|
| Col·lecció: | Journal of Lipid Research |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S0022227520327553 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|